The hard part is already done: the expensive phase of a major undertaking is finished, and the company is now in the col
The model's full reasoning — Q3 2019 call → NOWe need answer only YES or NO based on transcript. Need determine if management conveys recently finished heavy phase of major undertaking and now collecting with reported results still mostly reflecting paying phase. Transcript is Autodesk Q3 FY2019. They have been transitioning business model from perpetual/maintenance to subscription. This is a major multi-year undertaking. On call they discuss progress: "We built upon strength... accelerated growth... record growth in total ARR... highest growth quarter since started business model transition over four years ago." They crossed 4 million subscriptions. They have near completion of resource rebalancing? "spend was up 5%... sequential increase in spend related to continued hiring ramp that we’ve been calling out for past few quarters as we near the completion of the resource rebalancing." So heavy phase of transition? They mention "we are positioning company to expand technology leadership... committed to FY 2020 goals." But the transition is ongoing? They say "crossed 30% mark for sum of revenue growth and free cash flow margin. We look forward to nearly doubling that in next few years." Hmm. Question asks: Does management convey that company has RECENTLY FINISHED the expensive, uncertain, or heavy phase of a major undertaking and has now entered collecting phase, with reported results still mostly reflecting paying phase rather than collecting phase? Autodesk is in middle of business model transition. They are still transitioning maintenance to subscription, expect Q4 M2S subs increase. They continue to see "heavy" costs? They are "nearing completion of resource rebalancing" - that suggests heavy phase of hiring ramp is almost done. But the transition itself? They have completed "transition" maybe? They said "strength ARR result of acceleration... We are making terrific progress while remaining committed to FY 2020 goals." They have targets. The heavy phase of transition (spending, disruption) is arguably largely done? But they still have "maintenance to subscription program continues to perform well" and "we expect number of M2S subs to increase in Q4." They have "renewal rates" etc. The payoff is beginning: ARR growth, ARPS growth, billings.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| DAL | Delta Air Lines, Inc. | Q2 2023 | 2023-07-13 | A |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| ARCB | ArcBest Corporation | Q4 2016 | 2017-02-08 | C |
IONS · Q1 2017 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the heavy phase of the SPINRAZA program as concluded ("we concluded our costly Phase III program"), with R&D expenses now expected to decline as the company transitions to a multiproduct profitable organization. They note that Q1 marked the first full quarter of commercial revenues ($47 million), with royalties of 5.2 million reflecting the early stage of this new revenue stream, while the reported results still include substantial R&D revenue (102 million) and show profitability driven by the ongoing evolution toward sustained profitability. The commercial benefits are visibly beginning but remain early, with the numbers carrying the burden of the prior development effort.
PKOH · Q3 2022 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the phase where they collect...YES Management describes the restructuring of 14 global locations as "largely completed," with the cycle finished and no significant customer attrition. They are now pivoting to focus on the balance sheet and "harvesting some of the significant cash investments" made over the last couple of years, while noting that earnings are continuing to improve sequentially in Q4 despite inflation. The reported results show positive cash flow and improved metrics, but the harvest is described as beginning, with the $60 million working capital investment expected to convert over 12-18 months, indicating the collecting phase is early and the numbers still largely reflect the prior paying phase.
AKYA · Q2 2023 → YESThe question is about whether management conveys that the company has recently finished the expensive, uncertain, or heavy phase of a major undertaking and has now entered the collecting phase, with r...YES Management describes the first phase (2021–end of 2022) as having completed its core objectives: successful launch of Fusion, portfolio development, organizational expansion, and platform enhancements. They explicitly frame the second phase as now beginning, with the reported Q2 results still carrying the burden of that prior heavy investment (high OpEx, RIF charges, gross-margin pressure) while the new phase is visibly starting to deliver through record revenue, reagent pull-through, and cost-optimization moves. The numbers lag the crossing, as the company is still pre-profitability and targeting cash-flow positivity only in 2025.